| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/07/2005 | EP1602666A1 Novel protein and its dna |
| 12/07/2005 | EP1602664A1 HCV E1 comprising specific disulfide bridges |
| 12/07/2005 | EP1601967A2 Identification of antigen epitopes |
| 12/07/2005 | EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 12/07/2005 | EP1601770A2 Streptococcus pyogenes antigens |
| 12/07/2005 | EP1601757A2 Cell-polymer fiber compositions and use thereof |
| 12/07/2005 | EP1601698A1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 12/07/2005 | EP1601697A1 Antibody purification by Protein A and ion exchange chromatography |
| 12/07/2005 | EP1601695A1 Mcam inhibitors |
| 12/07/2005 | EP1601694A2 Uses of il-23 agonists and antagonists; related reagents |
| 12/07/2005 | EP1601683A2 Novel non-invasive marker for liver disease |
| 12/07/2005 | EP1601682A2 Compositions and methods for diagnosing and treating prostate cancer |
| 12/07/2005 | EP1601450A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 12/07/2005 | EP1601378A2 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| 12/07/2005 | EP1601377A2 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 12/07/2005 | EP1601374A2 Compositions and methods for diagnosing and treating an inflammation |
| 12/07/2005 | EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 12/07/2005 | EP1601330A2 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 12/07/2005 | EP1423409A4 Gastrokines and derived peptides including inhibitors |
| 12/07/2005 | EP1385886B1 Method for preparing human immunoglobulin concentrates for therapeutic use |
| 12/07/2005 | EP1230551B1 Methods to identify compounds that modulate neuronal activity |
| 12/07/2005 | EP1109579B1 Use of tgf-beta inhibitors for treating cerebral disorders |
| 12/07/2005 | EP1019514B1 A keratinocyte derived protease |
| 12/07/2005 | EP0922105B1 Infectious papillomavirus pseudoviral particles |
| 12/07/2005 | EP0873354B1 Novel amp activated protein kinase |
| 12/07/2005 | EP0716701B1 Agent comprising serine-threonine kinase for the diagnostic and therapy of tumors |
| 12/07/2005 | EP0615451B1 Novel cytokine that binds cd30 |
| 12/07/2005 | CN1705744A Transplantable cell |
| 12/07/2005 | CN1705491A Optimized Fc variants and methods for their generation |
| 12/07/2005 | CN1704432A TNF alpha high-affinity chimeric antibody and use thereof |
| 12/07/2005 | CN1230540C Drosophila recombination-associated protein and methods for use |
| 12/07/2005 | CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain |
| 12/07/2005 | CN1230536C Tie-2 ligands, methods of making and uses thereof |
| 12/07/2005 | CN1230447C Monoclonal antibody for identifying platelet membrane glycoprotein and its application for curing thrombus |
| 12/07/2005 | CN1230446C Antibodies and FV fragment recognizing antigen IORC2 |
| 12/07/2005 | CN1230445C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 12/07/2005 | CN1230201C Blood-platelet specific mosaic immune globulin and its using method |
| 12/06/2005 | USRE38916 detection of the germline and somatic alterations of wild-type APC (adenomatous polyposis coli) genes; used in cancer diagnostics and therapeutics |
| 12/06/2005 | US6972327 Regeneration of chromatography material |
| 12/06/2005 | US6972326 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
| 12/06/2005 | US6972324 Antibodies specific for CD44v6 |
| 12/06/2005 | US6972323 Anti-Fas antibodies |
| 12/06/2005 | US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 12/06/2005 | US6972318 Complex of a chaperone protein with amyloid |
| 12/06/2005 | US6972179 RRP sequences and knockout mice and uses thereof |
| 12/06/2005 | US6972176 KVLQT1—a long QT syndrome gene |
| 12/06/2005 | US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 12/06/2005 | US6972126 Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same |
| 12/06/2005 | US6972125 Comprising a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin; treating various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases |
| 12/06/2005 | CA2285700C Renin-active substance |
| 12/06/2005 | CA2208274C Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 12/06/2005 | CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use |
| 12/01/2005 | WO2005114222A1 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 12/01/2005 | WO2005114218A2 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 12/01/2005 | WO2005113786A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 12/01/2005 | WO2005113605A1 Cross-linked antibodies |
| 12/01/2005 | WO2005113604A2 Methods for immunoglobulin purification |
| 12/01/2005 | WO2005113603A1 Eradication of helicobacter infection by activation of stomach mast cells |
| 12/01/2005 | WO2005113602A1 Coiled-coil microbial antigens |
| 12/01/2005 | WO2005113601A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 12/01/2005 | WO2005113600A2 Methods for the control, treatment and management of obesity |
| 12/01/2005 | WO2005113587A2 Gene products expressed differentially in tumors and use thereof |
| 12/01/2005 | WO2005113586A2 Disease-associated proteins |
| 12/01/2005 | WO2005113584A1 Methods and compositions comprising protein l immunoglobulin binding domains for cell-specific targeting |
| 12/01/2005 | WO2005113059A2 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 12/01/2005 | WO2005113003A2 Method for augmenting b cell depletion |
| 12/01/2005 | WO2005113001A1 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 12/01/2005 | WO2005113000A2 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 12/01/2005 | WO2005112999A2 Cancer treatment with inhibitors of collagen synthesis |
| 12/01/2005 | WO2005112998A2 Compositions and methods for preventing erythropoietin-associated hypertension |
| 12/01/2005 | WO2005112997A2 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues |
| 12/01/2005 | WO2005112969A2 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 12/01/2005 | WO2005112893A1 Microspheres comprising protein and showing injectability at high concentrations of said agent |
| 12/01/2005 | WO2005112564A2 Germline and sequence variants of humanized antibodies and methods of making and using them |
| 12/01/2005 | WO2005103081A3 Human monoclonal antibodies against cd20 |
| 12/01/2005 | WO2005099776A9 Steroid sparing agents and methods of using same |
| 12/01/2005 | WO2005097832A3 Humanized anti-tgf-beta antibodies |
| 12/01/2005 | WO2005094391A3 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN |
| 12/01/2005 | WO2005090407A8 Human anti-epidermal growth factor receptor antibody |
| 12/01/2005 | WO2005087954A3 Roles of foxc2, pdgfr, vegfr3 in lymphatic vessel development |
| 12/01/2005 | WO2005087808A3 Growth factor binding constructs materials and methods |
| 12/01/2005 | WO2005074985A3 Methods of modulating cd200 and cd200r |
| 12/01/2005 | WO2005070967A3 Anti-cancer antibodies with reduced complement fixation |
| 12/01/2005 | WO2005065015A3 Neutralizing antibodies and methods of use thereof |
| 12/01/2005 | WO2005062916A3 Methods for generating multimeric molecules |
| 12/01/2005 | WO2005054509A3 Assay and treatment |
| 12/01/2005 | WO2005050200A3 Screening assays and methods of tumor treatment |
| 12/01/2005 | WO2005046721A3 Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 12/01/2005 | WO2005027831A3 Modulators of p-selectin glycoprotein ligand 1 |
| 12/01/2005 | WO2005023848A3 Adenoviral epitopes |
| 12/01/2005 | WO2004092343A3 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 12/01/2005 | WO2004048552A3 Modulating immune responses |
| 12/01/2005 | WO2004022718A3 Therapeutic human anti-il-1r1 monoclonal antibody |
| 12/01/2005 | WO2002092012A3 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 12/01/2005 | US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals |
| 12/01/2005 | US20050267294 Antibodies with increased affinities for anthrax antigens |
| 12/01/2005 | US20050267031 procytotoxic agents for use in treating cancer; antitumor agents; has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group |
| 12/01/2005 | US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders |
| 12/01/2005 | US20050266532 Albumin fusion proteins |
| 12/01/2005 | US20050266528 Proteolytic blood coagulation factor for treatment and prevention of preclampsia and thrombotic disorders |